See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI103.13▲ 3.68%
Euronext Brussels · Belgium · Updated after 22 Oct 2026 close

AGFA Gevaert NV

AGFB · Euronext Brussels · prices in EUR
EUR 0.406▼ -0.004 (1.10%)
Research reportHistorical data

About AGFA Gevaert NV

Agfa-Gevaert is a Belgian technology company that develops imaging products and systems. It supplies medical imaging equipment and software used by hospitals and radiology departments, and it provides consumables and systems for printing and graphic arts, including plates and prepress technology. The company also offers products for industrial applications such as non-destructive testing and specialty films. It is based in Belgium and serves customers in healthcare, printing and industrial markets around the world.

On this site AGFA Gevaert NV appears as a stock on the Euronext Brussels (Belgium), code AGFB, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

29/ 100
Market X-Ray · price-based
Weak price profile
Ranks #90 of 111 on the Euronext Brussels · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Belgium yet.
TrendWeak
27/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-8.9%
From 52-week high-52.3%
MomentumWeak
36/100
Lagging most stocks on this exchange.
See the numbers →
3-month return1.5%
6-month return-15.7%
12-month, skipping last month-54.2%
Stability (higher is calmer)Weak
15/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)51.9%
Worst drawdown, 1 year (smaller is calmer)-56.0%
LiquidityWeak
46/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.08M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Belgium when fundamentals data for this market is added. All Belgium stocks.
Price trend
Below its 200-day average
Versus its 50- and 200-day averages
52-week range
0.366 – 0.859
Price is 8% of the way up
Returns
+1.5% 3m · −51.1% 1y
Price returns, dividends not included
RSI (14)
45
Neutral zone

Price chart

52-wk range 0.366 – 0.859 Daily closes, split-adjusted

Signals

50-day average0.421
200-day average0.446
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.020

Technical summary

Daily
Strongly bearish
2 bullish · 2 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Strongly bearish
1 bullish · 0 neutral · 7 bearish
Moving averages (daily)
SMA 100.41Bearish
EMA 100.41Bearish
SMA 200.43Bearish
EMA 200.42Bearish
SMA 500.42Bearish
EMA 500.42Bearish
SMA 1000.41Bearish
EMA 1000.43Bearish
SMA 2000.45Bearish
EMA 2000.48Bearish
Oscillators (daily)
RSI (14)44.99Neutral
MACD (12, 26)0.00Bearish
Momentum (12)-5.80Bearish
Stochastic %K (14)7.32Bullish
Williams %R (14)-92.68Bullish
CCI (20)-62.51Neutral
Pivot points (classic, last session)
S3
0.40
S2
0.40
S1
0.40
Pivot
0.41
R1
0.41
R2
0.41
R3
0.42
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in EUR. Educational only, not financial advice.